Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept
Clinical trial NCT00581165 · COMPLETED
Trial details
- NCT number
- NCT00581165
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2007-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.